Aspasia Stamatoullas‐Bastard

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani et al. · Blood · 2017 · 234 citations · Full text

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Frédérik Damm, Olivier Kosmider, Véronique Gelsi‐Boyer et al. · Blood · 2012 · 230 citations

Itraconazole Oral Solution for Primary Prophylaxis of Fungal Infections in Patients with Hematological Malignancy and Profound Neutropenia: a Randomized, Double-Blind, Double-Placebo, Multicenter Trial Comparing Itraconazole and Amphotericin B

J L Harousseau, A. W. Dekker, Aspasia Stamatoullas‐Bastard et al. · Antimicrobial Agents and Chemotherapy · 2000 · 157 citations · Full text

Efficacy of chemotherapy or chemo‐anti‐PD‐1 combination after failed anti‐PD‐1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi, Julia Gilhodes, Marie Maerevoet et al. · American Journal of Hematology · 2018 · 116 citations · Full text

Survival after Hodgkin lymphoma

Olav Favier, Natacha Heutte, Aspasia Stamatoullas‐Bastard et al. · Cancer · 2009 · 76 citations · Full text